WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹109 Cr | ₹61 Cr | ₹9.13 Cr | ₹11 Cr | ₹25 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹109 Cr |
Mar2023 | ₹61 Cr |
Mar2022 | ₹9.13 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹25 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹109 Cr | 78.73 | |
Mar2023 | ₹61 Cr | 567.74 | |
Mar2022 | ₹9.13 Cr | -20.30 | |
Mar2021 | ₹11 Cr | -54.19 | |
Mar2020 | ₹25 Cr | - |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,874.3 Cr | -12.4% | -3.5% | 67% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,394.0 Cr | -6.7% | 2.6% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹142,920.0 Cr | -6.6% | -3.7% | 43.8% | Stock Analytics | |
CIPLA | ₹114,383.0 Cr | -5.3% | -2.9% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,817.0 Cr | -3.8% | 1.8% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹91,385.4 Cr | -4.9% | -3.3% | -10.2% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -12.4% |
-3.5% |
67% |
SENSEX | -3.6% |
-0.7% |
-0.5% |
You may also like the below Video Courses